Once - daily amoxicillin versus twice - daily penicillin V in <font color="red">group_2</font> <font color="red">A_2</font> <font color="red">beta_2</font> <font color="red">-_2</font> <font color="red">haemolytic_2</font> <font color="red">streptococcal_2</font> <font color="red">pharyngitis_2</font> <font color="red">._2</font> 
<br>
<br> BACKGROUND Rheumatic fever is a preventable chronic disease preceded by <font color="red">group_2</font> <font color="red">A_2</font> <font color="red">beta_2</font> <font color="red">-_2</font> <font color="red">haemolytic_2</font> <font color="red">streptococcal_2</font> <font color="red">(_2</font> <font color="red">GABHS_2</font> <font color="red">)_2</font> <font color="red">pharyngitis_2</font> <font color="red">._2</font> 
<br> OBJECTIVE To test the non - inferiority of once - daily ( QD ) oral amoxicillin to the recommended twice - daily ( BID ) oral penicillin V in <font color="red">GABHS_2</font> <font color="red">pharyngitis_2</font> <font color="red">._2</font> 
<br> METHODS This was a randomised non - inferiority trial carried out in a <font color="red">school_1</font> <font color="red">-_1</font> <font color="red">based_1</font> <font color="red">clinic_1</font> <font color="red">in_1</font> <font color="red">New_1</font> <font color="red">Zealand_1</font> <font color="red">._1</font> <font color="red">Children_2</font> <font color="red">presenting_2</font> <font color="red">with_2</font> <font color="red">GABHS_2</font> <font color="red">pharyngitis_2</font> were randomised to oral amoxicillin 1500 mg QD ( or 750 mg if bodyweight was < or=30 kg ) or to oral penicillin V 500 mg BID ( or 250 mg if bodyweight was < or=20 kg ) for 10 days . Observed medication and weekend diary cards were used to monitor adherence . 
<br> OUTCOME Eradication of <font color="red">GABHS_1</font> <font color="red">,_1</font> determined with follow - up throat cultures on days 3 - 6 , 12 - 16 and 26 - 36 . <font color="red">GABHS_1</font> isolates were serotyped to distinguish bacteriological treatment failures ( and relapses ) from new acquisitions . Non - inferiority was defined as an upper 95% confidence limit ( CL ) for the difference in success of eradication in the amoxicillin and penicillin V treatment groups of < or=10% . 
<br> RESULTS <font color="red">353_1</font> <font color="red">children_1</font> <font color="red">with_1</font> <font color="red">positive_1</font> <font color="red">throat_1</font> <font color="red">swabs_1</font> <font color="red">for_1</font> <font color="red">GABHS_2</font> were randomised to amoxicillin ( n = 177 ) or penicillin V ( n = 176 ) . The upper 95% CL for the differences in positive cultures between the antibiotics was 4.9% at days 3 - 6 , 6.5% at days 12 - 16 and 8.5% at days 26 - 36 . Treatment failures ( including relapses ) occurred at each visit in 5.8% , 12.7% and 10.7% of amoxicillin recipients and 6.2% , 11.9% and 11.3% of penicillin V recipients , respectively . No significant differences in resolution of symptoms were noted between treatment groups . One case of unsubstantiated acute rheumatic fever occurred after 7 days of amoxicillin . 
<br> CONCLUSION In this adequately powered study , once - daily oral amoxicillin is not inferior to twice - daily penicillin V for the treatment and eradication of <font color="red">GABHS_2</font> <font color="red">in_2</font> <font color="red">children_2</font> <font color="red">with_2</font> <font color="red">pharyngitis_2</font> <font color="red">._2</font>